63 results
Page 3 of 4
8-K
EX-99.1
w1w6n9zw9d
6 May 20
Axcella Announces Positive Top-Line Data from AXA1125-003 Clinical Study Showing Multifactorial Activity in Adult Subjects with NAFLD
8:09am
DEFA14A
mir8akha
3 Apr 20
Additional proxy soliciting materials
4:19pm
DEF 14A
qgzw1
3 Apr 20
Definitive proxy
4:15pm
DRS
ddzzx 4uzakfd129
3 Apr 20
Draft registration statement
12:00am
10-K
ifj2ey8zurur
23 Mar 20
Annual report
4:12pm
8-K
EX-10.1
yyit oatz5
25 Nov 19
Axcella Strengthens Executive Team with Key Addition and Promotion
8:11am
10-Q
94cqah0
20 Jun 19
Quarterly report
5:03pm
424B4
69u176alz43a2
9 May 19
Prospectus supplement with pricing info
4:29pm
S-1/A
EX-1.1
bk2ychbe0is zizk
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
EX-10.10
etwh7yek
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
EX-10.2
s6b42jxy
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
EX-10.12
t3v8f54v xoqxycgr9
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
a4qu3wxd2yu27s9dr1
30 Apr 19
IPO registration (amended)
6:06am
CORRESP
p9a302f6kg gq
24 Apr 19
Correspondence with SEC
12:00am
S-1
EX-4.2
hvswusow7yxxds6tf9jq
12 Apr 19
IPO registration
7:02am